And in this corner ...
Abbott's acquisition of Kos creates a viable contender in the fight for cardiovascular market share.
'Average Wholesale Price' Means Lawsuits for Pharma
Judge defines term ahead of Medicare fraud trial.
On the Right Track
After decades of disparate attempts to secure supply chains, pharma companies may finally be getting on the same page.
